These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 9442172

  • 21. Age-specific levels for basal follicle-stimulating hormone assessment of ovarian function.
    Barad DH, Weghofer A, Gleicher N.
    Obstet Gynecol; 2007 Jun; 109(6):1404-10. PubMed ID: 17540814
    [Abstract] [Full Text] [Related]

  • 22. High live birth rate in the subsequent IVF cycle after first-cycle poor response among women with mean age 35 and normal FSH.
    Moolenaar LM, Mohiuddin S, Munro Davie M, Merrilees MA, Broekmans FJ, Mol BW, Johnson NP.
    Reprod Biomed Online; 2013 Oct; 27(4):362-6. PubMed ID: 23953583
    [Abstract] [Full Text] [Related]

  • 23. [Impact of elevated basal follicle-stimulating hormone on the quantity and quality of oocytes and embryos and pregnancy outcomes in young women].
    Chen SL, Luo YQ, Xia R, Chen X, Shi XY, Zheng HY, Wang LL, Wu YQ.
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 May; 31(5):777-81. PubMed ID: 21602123
    [Abstract] [Full Text] [Related]

  • 24. Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged ≥35 years: a randomized controlled trial.
    Vuong TN, Phung HT, Ho MT.
    Hum Reprod; 2015 May; 30(5):1188-95. PubMed ID: 25740882
    [Abstract] [Full Text] [Related]

  • 25. Repeated clomiphene citrate challenge testing in the prediction of outcome in IVF: a comparison with basal markers for ovarian reserve.
    Hendriks DJ, Broekmans FJ, Bancsi LF, de Jong FH, Looman CW, Te Velde ER.
    Hum Reprod; 2005 Jan; 20(1):163-9. PubMed ID: 15471926
    [Abstract] [Full Text] [Related]

  • 26. Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?
    Drakopoulos P, Blockeel C, Stoop D, Camus M, de Vos M, Tournaye H, Polyzos NP.
    Hum Reprod; 2016 Feb; 31(2):370-6. PubMed ID: 26724797
    [Abstract] [Full Text] [Related]

  • 27. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization.
    Nardo LG, Gelbaya TA, Wilkinson H, Roberts SA, Yates A, Pemberton P, Laing I.
    Fertil Steril; 2009 Nov; 92(5):1586-93. PubMed ID: 18930213
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Elevated levels of basal estradiol-17beta predict poor response in patients with normal basal levels of follicle-stimulating hormone undergoing in vitro fertilization.
    Evers JL, Slaats P, Land JA, Dumoulin JC, Dunselman GA.
    Fertil Steril; 1998 Jun; 69(6):1010-4. PubMed ID: 9627285
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. A mild ovarian stimulation strategy in women with poor ovarian reserve undergoing IVF: a multicenter randomized non-inferiority trial.
    Youssef MA, van Wely M, Al-Inany H, Madani T, Jahangiri N, Khodabakhshi S, Alhalabi M, Akhondi M, Ansaripour S, Tokhmechy R, Zarandi L, Rizk A, El-Mohamedy M, Shaeer E, Khattab M, Mochtar MH, van der Veen F.
    Hum Reprod; 2017 Jan; 32(1):112-118. PubMed ID: 27836979
    [Abstract] [Full Text] [Related]

  • 32. A randomized single-blind controlled trial of letrozole as a low-cost IVF protocol in women with poor ovarian response: a preliminary report.
    Goswami SK, Das T, Chattopadhyay R, Sawhney V, Kumar J, Chaudhury K, Chakravarty BN, Kabir SN.
    Hum Reprod; 2004 Sep; 19(9):2031-5. PubMed ID: 15217999
    [Abstract] [Full Text] [Related]

  • 33. Inhibin, follicle-stimulating hormone, and age as predictors of ovarian response in in vitro fertilization cycles stimulated with gonadotropin-releasing hormone agonist-gonadotropin treatment.
    Balasch J, Creus M, Fábregues F, Carmona F, Casamitjana R, Ascaso C, Vanrell JA.
    Am J Obstet Gynecol; 1996 Nov; 175(5):1226-30. PubMed ID: 8942492
    [Abstract] [Full Text] [Related]

  • 34. Moderately elevated levels of basal follicle-stimulating hormone in young patients predict low ovarian response, but should not be used to disqualify patients from attempting in vitro fertilization.
    Luna M, Grunfeld L, Mukherjee T, Sandler B, Copperman AB.
    Fertil Steril; 2007 Apr; 87(4):782-7. PubMed ID: 17207802
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Basal follicle--stimulating hormone levels on day 3 of previous cycle are predictive of in vitro fertilization outcome.
    Pruksananonda K, Boonkasemsanti W, Virutamasen P.
    J Med Assoc Thai; 1996 Jun; 79(6):365-9. PubMed ID: 8855610
    [Abstract] [Full Text] [Related]

  • 38. The prognostic value of age and follicle-stimulating hormone levels in women over forty years of age undergoing in vitro fertilization.
    Watt AH, Legedza AT, Ginsburg ES, Barbieri RL, Clarke RN, Hornstein MD.
    J Assist Reprod Genet; 2000 May; 17(5):264-8. PubMed ID: 10976413
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Low circulating anti-Müllerian hormone and normal follicle stimulating hormone levels: which prognosis in an IVF program?].
    Grzegorczyk-Martin V, Khrouf M, Bringer-Deutsch S, Mayenga JM, Kulski O, Cohen-Bacrie P, Benaim JL, Belaisch-Allart J.
    Gynecol Obstet Fertil; 2012 May; 40(7-8):411-8. PubMed ID: 22521986
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.